Next-generation pulse oximeters to enhance patient care
Our high-precision pulse oximeter accurately measures blood oxygen levels for every patient.
OUR MISSION
Kofimi Technology, Inc. is an early-stage medical device company spun out of Prof. Valencia Koomson’s Advanced Integrated Circuits and Systems Lab at Tufts University.
Kofimi’s flagship device, ChromaSense™, is powered by advanced semiconductor technology and AI signal processing to deliver high-precision blood oxygen readings.
Kofimi’s flagship device, ChromaSense™, is powered by advanced semiconductor technology and AI signal processing to deliver high-precision blood oxygen readings.
The Problem with Current Pulse Oximeters
2022 New York Times Article | Doctors Warn F.D.A. of Health Risks Posed by Flawed Oxygen Devices.
Pulse oximeter errors can lead to misdiagnosis and underdiagnosis of disease and delays in treatment resulting in health disparities.
Bias in Readings
FDA safety communication warns of pulse oximeter limitations and risk of inaccuracy due to skin tone, poor blood circulation, and other factors.
SOLUTION
Transforming Pulse Oximetry
Preliminary testing has demonstrated the accuracy of ChromaSenseTM compared to the gold-standard arterial blood gas reading over a range of skin tones.
Technology
- Medical-grade vital sign data
- Self-calibrating
- User-friendly interface
- Seamless integration
- Motion compensation
Applications
- In-hospital clinical care
- Home-based care:
- Telehealth and remote patient monitoring
- Chronic disease management
- Screening for respiratory disorders
- Newborn screening for congenital heart defects
- Clinical and home sleep testing
ChromaSense™ overcomes existing limitations of pulse oximeter technology by providing a bias-free measurement in the midst of noise and variability from the environment (ambient light) and users (skin tone, blood perfusion, motion).
Cloud-based storage capabilities of the device enable compatibility with tele health applications to meet the global market demand for remote health monitoring tools.
OUR PARTNERS





Our Team
Currently advancing through our roadmap, ChromaSense™ represents the future of pulse oximetry. With regulatory milestones and manufacturing strategies in progress, it’s poised to redefine precision and accessibility in patient care.
Members of the Kofimi team at the Massachusetts Life Sciences Innovation Day